CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $84,510 | +43.8% | 5,668 | +5.6% | 0.00% | +33.3% |
Q2 2023 | $58,780 | +208.2% | 5,368 | -12.5% | 0.00% | +200.0% |
Q1 2022 | $19,071 | -73.9% | 6,132 | -69.4% | 0.00% | 0.0% |
Q3 2021 | $73,150 | -28.1% | 20,041 | -10.5% | 0.00% | -50.0% |
Q1 2021 | $101,710 | +66.9% | 22,403 | +111.1% | 0.00% | +100.0% |
Q4 2020 | $60,924 | -43.4% | 10,614 | -28.6% | 0.00% | -50.0% |
Q3 2020 | $107,666 | +28.2% | 14,871 | -38.2% | 0.00% | +100.0% |
Q2 2020 | $84,015 | -20.3% | 24,073 | +16.9% | 0.00% | -50.0% |
Q3 2019 | $105,467 | -26.0% | 20,599 | +3.5% | 0.00% | 0.0% |
Q2 2019 | $142,484 | -46.1% | 19,900 | 0.0% | 0.00% | -60.0% |
Q1 2019 | $264,272 | +68.7% | 19,900 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $156,613 | -29.0% | 19,900 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $220,492 | -99.9% | 19,900 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $267,058,000 | – | 19,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |